Pic credit: ANI
NEW DELHI: The Defence Research and Development Organisation's (DRDO) on Tuesday said that the anti-Covid drug 2DG is
approved for emergency use as an adjunct therapy to the standard of care in the treatment of coronavirus patients in hospital settings.
The DRDO said that anti-Covid drug 2DG can now be given to Covid 19 patients under the care and prescription of doctors.
DRDO also issued some important guidelines with regard to its anti-Covid -19 drug.
"Ideally, 2DG should be prescribed as early as possible by doctors for moderate to severe Covid patients for a maximum duration of up to 10 days," it said.